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the amphipathic helix of M2 would first
contact a cholesterol-rich environment;
then as the virus completes assembly,
M2 would eventually contact surrounding
membrane regions with less cholesterol.
At this point, M2 could promote scission
by modifying the line tension between
the bud and the bulk plasma mem-
brane (Figure 1). This mechanism, how-
ever, relies on forces generated at the
boundary of two lipid domains. This is
perhaps not the complete story because
M2 can drive vesicle budding and
detachment even from simple model
membranes that lack lipids commonly
involved in establishing such membrane
domains.Clearly, the study by Rossman and
colleagues marks only the beginning of
a fascinating story that will shed new light
on a fundamental but still poorly under-
stood stage in the life cycle of enveloped
viruses. In addition, their study identifies
yet another essential function of the M2
channel. It will be interesting to see if
M2’s role in budding can be exploited as
a drug target to treat influenza.REFERENCES
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Cells possess internal 24 hr or circadian clocks that synchronize physiological processes with
daily cycles of light and nutrient availability. In this issue, Asher et al. (2010) find that PARP-1
(poly(ADP-ribose) polymerase 1) modifies components of the clock machinery in response to
feeding, providing a mechanism for how metabolic rhythms coordinate with circadian rhythms.Many organisms synchronize their
behavior, physiology, and metabolism
with the 24 hr rotation of the Earth. In
mammals, a master pacemaker is located
in the hypothalamic region called the
suprachiasmatic nucleus (SCN), which
contains a cluster of 10,000 neurons.
Each SCN neuron expresses a transcrip-
tional feedback loop that self-generates
an oscillation with a period of 24 hr
(Green et al., 2008). Cells in peripheral
tissues, such as the liver, contain similar
cell-autonomous clocks, and the SCN
synchronizes the oscillation of their
internal clocks to coordinate rhythms
throughout the body. However, in both
the SCN and peripheral tissues, the
molecular clocks must integrate extracel-
lular cues to maintain synchrony with theenvironment. Light is the dominant cue
for the central clock in the SCN, but for
peripheral tissues, metabolic cycles,
such as feeding and fasting, can also
regulate the internal clocks.
The link between circadian and meta-
bolic rhythms is an area of intense study
because disrupting the synchrony is
thought to contribute to the etiology of
disorders such as diabetes, obesity, and
cardiovascular disease (Green et al.,
2008). Nonetheless, how circadian and
metabolic systems interact remains
largely undefined; in particular, how feed-
ing directly modulates the molecular
oscillators in peripheral tissues has been
a mystery. In this issue of Cell, Asher
et al. (2010) find that the activity of poly
(ADP-ribose) polymerase 1 (PARP-1) inthe liver of mice oscillates in synchrony
with the feeding-fasting cycle, providing
a new link betweenmetabolism and circa-
dian rhythms.
PARP-1 is a highly conserved nuclear
protein that adds chains of ADP-ribose
molecules to proteins in a process called
ADP-ribosylation (or poly ADP-ribosyla-
tion). PARP-1 uses nicotinamide adenine
dinucleotide (NAD+) to synthesize these
polymers, which can include up to
200 ADP-ribose units. Like other post-
translational modifications, ADP-ribosyla-
tion alters protein function; chains of
ADP-ribose are negatively charged,
and thus their addition is believed to
disrupt electrostatic interactions, such
as those involved in DNA binding. The
major substrate of PARP-1 is itself, andptember 17, 2010 ª2010 Elsevier Inc. 841
Figure 1. PARP-1 Links the Circadian Clock with Metabolic Rhythms
(A) The molecular clock in cells is composed of an autoregulatory feedback loop that takes 24 hr to
complete. The transcription factors CLOCK and BMAL1 bind to E boxes and activate the negative arm
of the feedback loop by triggering gene expression of their own repressors, Cryptochrome (Cry) and
Period (Per). In response to feeding, PARP-1 poly-ADP-ribosylates (i.e., ADP-ribosylates) CLOCK (Asher
et al., 2010), which inhibits DNA binding by CLOCK-BMAL1. In contrast, Sirtuin 1 (SIRT1) modulates
BMAL1 by deacetylating it.
(B) Circadian rhythms exert a strong influence over metabolic rhythms by controlling the timing of behav-
iors, such as feeding and sleep. Metabolic genes, such as AMP-activated protein kinase (AMPK), regulate
levels of NAD+. The activities of PARP-1 and SIRT1 are directly modulated by NAD+, and these enzymes
feedback to regulate circadian genes.auto-ADP-ribosylation inhibits DNA bind-
ing of PARP-1 (D’Amours et al., 1999).
AlthoughPARP-1wasoriginally charac-
terized as a protein involved in the DNA
repair pathway, recent evidence suggests
that PARP-1 plays crucial roles in many
processes, including chromatin remodel-
ing and transcription (Krishnakumar and
Kraus, 2010). Furthermore, the catalytic
activity of PARP-1 is regulated by many
factors, including NAD+ levels, allosteric
interactions with chromatin and transcrip-842 Cell 142, September 17, 2010 ª2010 Elstion factors, and numerous types of post-
translationalmodifications, such asacety-
lation, phosphorylation, sumoylation, and
auto-ADP-ribosylation (D’Amours et al.,
1999).
Now Asher et al. (2010) show that the
ADP-ribosylation activity of PARP-1 oscil-
lates with a circadian pattern in the liver of
mice. Using a combination of in vitro and
in vivo approaches, the authors find
that PARP-1 ADP-ribosylates itself ina
rhythmic manner, with the peak activityevier Inc.occurring at the beginning of the light
phase when mice consume little food.
Surprisingly, this rhythmic activity of
PARP-1 is still present when the circadian
clock in the cell has been suppressed;
however, its phase can be shifted by
altering the feeding time. Thus, oscillations
of PARP-1 activity in the liver appear to be
regulated by feeding signals rather than
by components of the circadian clock.
But what about the converse? Could
the oscillations in PARP-1 activity help to
synchronize the endogenous clock with
the feeding-fasting cycle? To address
this question, the authors determined if
PARP-1 interacted with two central com-
ponents of the cellular clock, CLOCK
and BMAL1 (brain and muscle aryl hydro-
carbon receptor nuclear translocator
[ARNT]-like). CLOCK and BMAL1 hetero-
dimerize to activate transcription of their
repressors, Period (Per) and Crypto-
chrome (Cry), whose protein products
form a complex involved in the negative
feedback loop of the cell’s internal clock
(Figure 1). Asher and colleagues find that
PARP-1 not only interacts with these tran-
scriptions factors, but it also ADP-ribosy-
lates CLOCK with a circadian rhythm that
mirrors the oscillations of its own auto-
ADP-ribosylation. Moreover, ADP-ribosy-
lation of CLOCK reduces its binding to
DNA and possibly alters transcription of
its target genes (Figure 1). Taken together,
these results indicate thatPARP-1 is a crit-
ical player in a pathway that connects
nutrient intake to the molecular clock of
liver cells.
The regulation of PARP-1 by nutrient
intake is the latest discovery linking circa-
dian rhythm to metabolism and energy
balance (Green et al., 2008). Many meta-
bolic hormones, including insulin, leptin,
and corticosterone, exhibit circadian
oscillations, and the SCN also regulates
metabolism by modulating key transport
systems and metabolic enzymes. CLOCK
and BMAL1 themselves directly regulate
numerous nuclear receptors involved in
lipid and glucose metabolism and adipo-
genesis, including REV-ERBa and PPARa
(peroxisome proliferator-activated recep-
tors) (Froy and Miskin, 2010). Disrupting
the Clock gene in mice induces many
symptoms of metabolic syndrome, in-
cluding obesity, hyperlipidemia, high-
circulating glucose, and low-circulating
insulin (reviewed in Green et al., 2008).
Similarly, deleting Bmal1 in the pancreas
leads to hypoinsulinaemia and diabetes
(Marcheva et al., 2010).
Although metabolism is thought to be
primarily downstreamof the cellular clock,
numerous studies provide evidence that
metabolic cycles can operate indepen-
dently from or even influence circadian
rhythms. For example, when animals are
given meals at only one particular time
each day, their behavior and physiology
adjust to the restricted feeding regime;
over a period of time, they anticipate the
arrival of food. This behavior can be en-
trained by altering feeding time. This
observation led to the hypothesis that
a food-entrainable oscillator exists that is
distinct from the circadian oscillator in
the SCN (Green et al., 2008).
Asher and colleagues find that disrupt-
ing the Parp-1 gene in mice impairs the
ability of liver cells to adapt to changes
in the feeding schedule. When the authors
switched the feeding time from night to
day, the oscillations of PARP-1 activity in
liver cells of wild-type mice synchronized
with the feeding schedule after 4 days,
but this entrainment was significantly
delayed in the mice lacking Parp-1.
Thus, PARP-1 appears to contribute to
the cellular machinery that entrains with
the feeding-fasting cycle. Furthermore,
mice lacking the Parp-1 gene have
a slightly longer circadian period than
wild-type mice, suggesting that PARP-1
may feedback and alter the master circa-
dian clock in the SCN.Daily oscillations in PARP-1 activity also
have implications for cellular levels of
NAD+ and the function of Sirtuin 1 (SIRT1).
An NAD+-dependent deacetylase, SIRT1
is involved in energy homeostasis together
with the AMP-activated protein kinase
(AMPK) (Figure1).AMPK isanothernutrient
sensor, and it regulates SIRT1 activity by
controlling levels of NAD+. Thus, AMPK
may also control PARP-1 activity (Canto
and Auwerx, 2009). SIRT1 can regulate
the activity of BMAL1 and PER2 by deace-
tylation (Figure 1) (Asher et al., 2008;
Nakahata et al., 2008). Furthermore,
PARP-1 and SIRT1 potentially compete
for a limited pool of NAD+; SIRT1 can
directly regulate PARP-1 activity by deace-
tylation (Krishnakumar and Kraus, 2010);
and, these two enzymes appear to antago-
nize each other functionally (Kolthur-
Seetharam et al., 2006). Therefore, charac-
terizing the interplay among PARP-1,
SIRT1, and AMPK in response to nutrients
will be important in determining how circa-
dian and metabolic rhythms are linked.
Asher and colleagues describe a new
role for PARP-1, and as is the case in
most new discoveries, their results raise
as many questions as they answer. Fore-
most, it is not clear what regulates the
rhythmic activation of PARP-1. Although
an obvious candidate is NAD+ availability,
Asher and colleagues find that excess
NAD+ does not alter the oscillations in
PARP-1 activity. Given the numerous
mechanisms through which PARP-1 can
be activated, it will be challenging toCell 142, Sepinpoint the exact one operating here.
Nevertheless, the work presented by
Asher and colleagues adds a new dimen-
sion to the biology of PARP-1 and iden-
tifies an important link between metabolic
and circadian rhythms.
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